Royalty Pharma plc (RPRX) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Royalty Pharma PLC RPRX
$53.31
▲ +0.11%
(+$0.06)
Open
$53.23
Prev Close
$53.25
Day Range
$52.93 – $53.47
52W Range
$32.15 – $53.29
Market Cap
$30.67B
P/E (TTM)
37.14
Beta
0.41
Div Yield
1.77%
EPS (TTM)
$1.48
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-06-16 |
| Shares Out. | 576,940,000 |
| Website | royaltypharma.com/ ↗ |
| Phone | 12128830200 |
Royalty Pharma PLC is a publicly traded company under the ticker symbol RPRX on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
16 analysts (2026-05-01)
📰 Latest News for RPRX
Transcript : Royalty Pharma plc Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 10
Royalty Pharma : Q1 2026 Financial Results Call Transcript
Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update
Income Investors Should Know That Royalty Pharma plc (NASDAQ:RPRX) Goes Ex-Dividend Soon
Why One Fund’s $4 Million Centerra Gold Exit Looks Like Profit-Taking Amid a 150% Rally
Dividend Champion, Contender, And Challenger Highlights: Week Of May 10
This Fund Cashed Out of Preformed Line Products Amid a 150% Stock Surge